Apr 18, 2024

Which ASX companies are resurrecting abandoned drugs? Part 3

DEP is based on dendrimers, which are highly branched polymers, to enhance the delivery of cancer treatments and reduce toxic side effects such as neutropenia, nausea, severe diarrhoea and hair loss from chemotherapy agents. Read the full article in The Australian Business Review. 

 This contains certain forward-looking statements.